0GRZ Stock Overview
A medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
RaySearch Laboratories AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 235.00 |
| 52 Week High | SEK 282.00 |
| 52 Week Low | SEK 113.99 |
| Beta | 1.15 |
| 1 Month Change | -1.08% |
| 3 Month Change | 2.62% |
| 1 Year Change | 102.65% |
| 3 Year Change | 413.10% |
| 5 Year Change | 212.08% |
| Change since IPO | 277.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0GRZ | GB Healthcare Services | GB Market | |
|---|---|---|---|
| 7D | 8.6% | 3.0% | 4.7% |
| 1Y | 102.6% | -33.7% | 2.3% |
Return vs Industry: 0GRZ exceeded the UK Healthcare Services industry which returned -33.7% over the past year.
Return vs Market: 0GRZ exceeded the UK Market which returned 2.3% over the past year.
Price Volatility
| 0GRZ volatility | |
|---|---|
| 0GRZ Average Weekly Movement | 8.1% |
| Healthcare Services Industry Average Movement | 6.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in GB Market | 10.6% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: 0GRZ's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0GRZ's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 416 | Johan Lof | www.raysearchlabs.com |
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment planning and oncology information systems. The company offers RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, and electron beam radiation therapy; and µ-RayStation, a software platform for planning and evaluation in small animal irradiation research.
RaySearch Laboratories AB (publ) Fundamentals Summary
| 0GRZ fundamental statistics | |
|---|---|
| Market cap | SEK 7.99b |
| Earnings (TTM) | SEK 203.51m |
| Revenue (TTM) | SEK 1.19b |
39.3x
P/E Ratio6.7x
P/S RatioIs 0GRZ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0GRZ income statement (TTM) | |
|---|---|
| Revenue | SEK 1.19b |
| Cost of Revenue | SEK 99.49m |
| Gross Profit | SEK 1.09b |
| Other Expenses | SEK 889.02m |
| Earnings | SEK 203.51m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | 5.94 |
| Gross Margin | 91.65% |
| Net Profit Margin | 17.07% |
| Debt/Equity Ratio | 0% |
How did 0GRZ perform over the long term?
See historical performance and comparisonDividends
1.3%
Current Dividend Yield51%
Payout RatioDoes 0GRZ pay a reliable dividends?
See 0GRZ dividend history and benchmarks| RaySearch Laboratories dividend dates | |
|---|---|
| Ex Dividend Date | May 23 2025 |
| Dividend Pay Date | May 30 2025 |
| Days until Ex dividend | 34 days |
| Days until Dividend pay date | 41 days |
Does 0GRZ pay a reliable dividends?
See 0GRZ dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/18 03:49 |
| End of Day Share Price | 2025/04/17 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
RaySearch Laboratories AB (publ) is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Hans Mähler | DNB Markets |
| Hans Mähler | Handelsbanken Capital Markets |